Search Results
Jan 07, 2026, 07:00 ET Evogene and Unravel Biosciences Announce Collaboration to Develop a First-in-Class Therapy to Reverse Neurological Damage in Demyelinating Disorders
REHOVOT, Israel and BOSTON, January 7, 2026 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering computational chemistry company, specializing in the generative design of small molecules for the pharmaceutical and agricultural
More news about: Evogene
Dec 30, 2025, 07:00 ET Evogene Announces Appointment of Dr. Olga Nissan as its Vice President of Business Development
REHOVOT, Israel, Dec. 30, 2025 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering company in computational chemistry specializing in the generative design of small molecules for the pharmaceutical and agricultural
More news about: Evogene
Nov 20, 2025, 07:00 ET Evogene Reports Third Quarter 2025 Financial Results
REHOVOT, Israel, Nov. 20, 2025 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering company in computational chemistry specializing in the generative design of small molecules for the pharmaceutical and agricultural
More news about: Evogene
Nov 11, 2025, 07:00 ET Casterra and Fantini Partner to Advance Agricultural Mechanization for Scalable Commercial Castor Farming
an Israeli developer of high-yield castor seed varieties and integrated castor farming solutions — and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), and Fantini Italia S.R.L. ("Fantini"), a leading Italian developer and manufacturer of agricultural harvesting equipment, today
More news about: Casterra Ag Ltd.
Nov 06, 2025, 09:00 ET Evogene Schedules Third Quarter 2025 Financial Results Release
REHOVOT, Israel, Nov. 6, 2025 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural
More news about: Evogene